RANKINGS

Highest Net Margin — Healthcare

Net profit margin shows the percentage of revenue that translates into profit.

180 companies with Net Margin data.

Ranked by Net Margin(180)

#	Ticker	Name	Industry	Market Cap	Net Margin
1	KYNB	KYNTRA BIO, INC. TTM · 2026-06-30 Analysis WACC DCF	Pharmaceuticals	$25M	3968.6%
2	ORMP	ORAMED PHARMACEUTICALS INC. FY · 2025-12-31 Analysis WACC DCF	Pharmaceuticals	$178M	3202.5%
3	TRAW	Traws Pharma, Inc. TTM · 2025-09-30 Analysis WACC DCF	Pharmaceuticals	$6M	3001.6%
4	ABEO	ABEONA THERAPEUTICS INC. FY · 2025-12-31 Analysis WACC DCF	Pharmaceuticals	$280M	1223.1%
5	RIGL	RIGEL PHARMACEUTICALS, INC. TTM · 2026-06-30 Analysis WACC DCF	Pharmaceuticals	$912M	116.3%
6	NNNN	Anbio Biotechnology FY · 2025-12-31 Analysis WACC DCF	Biotechnology	$194M	74.1%
7	LGND	LIGAND PHARMACEUTICALS INCORPORATED TTM · 2026-06-30 Analysis WACC DCF	Pharmaceuticals	$6.2B	67.9%
8	INVA	INNOVIVA, INC. FY · 2025-12-31 Analysis WACC DCF	Pharmaceuticals	$1.5B	65.9%
9	TGTX	TG THERAPEUTICS, INC. TTM · 2026-06-30 Analysis WACC DCF	Pharmaceuticals	$8.5B	55.2%
10	UTHR	United Therapeutics Corporation TTM · 2026-06-30 Analysis WACC DCF	Pharmaceuticals	$23.6B	41.6%
11	CRON	CRONOS GROUP INC. TTM · 2026-06-30 Analysis WACC DCF	Pharmaceuticals	$1.2B	39.1%
12	EXEL	Exelixis Inc TTM · 2026-07-03 Analysis WACC DCF	Pharmaceuticals	$14.8B	35.3%
13	ACAD	ACADIA PHARMACEUTICALS INC. TTM · 2026-06-30 Analysis WACC DCF	Pharmaceuticals	$3.3B	33.4%
14	VRTX	VERTEX PHARMACEUTICALS INC / MA FY · 2025-12-31 Analysis WACC DCF	Pharmaceuticals	$128.5B	32.9%
15	CF	CF INDUSTRIES HOLDINGS, INC. TTM · 2026-06-30 Analysis WACC DCF	Other	$17.3B	32.3%
16	LLY	ELI LILLY AND COMPANY FY · 2025-12-31 Analysis WACC DCF	Pharmaceuticals	$1.1T	31.7%
17	JNJ	Johnson & Johnson FY · 2025-12-28 Analysis WACC DCF	Pharmaceuticals	$635.6B	28.5%
18	REGN	REGENERON PHARMACEUTICALS, INC. TTM · 2026-06-30 Analysis WACC DCF	Pharmaceuticals	$78.5B	27.9%
19	ZTS	Zoetis Inc. TTM · 2026-06-30 Analysis WACC DCF	Pharmaceuticals	$31.3B	27.5%
20	IDXX	IDEXX LABORATORIES INC /DE TTM · 2026-06-30 Analysis WACC DCF	Biotechnology	$41.3B	25.0%
21	HALO	HALOZYME THERAPEUTICS, INC. TTM · 2026-06-30 Analysis WACC DCF	Pharmaceuticals	$12.6B	24.9%
22	PLX	PROTALIX BIOTHERAPEUTICS, INC. TTM · 2026-06-30 Analysis WACC DCF	Pharmaceuticals	$224M	23.5%
23	AMGN	Amgen Inc. TTM · 2026-06-30 Analysis WACC DCF	Pharmaceuticals	$225.8B	23.0%
24	REX	REX AMERICAN RESOURCES CORPORATION TTM · 2026-07-31 Analysis WACC DCF	Other	$1.4B	22.5%
25	UG	UNITED-GUARDIAN, INC. TTM · 2026-06-30 Analysis WACC DCF	Other	$32M	22.0%
26	NBIX	NEUROCRINE BIOSCIENCES, INC. TTM · 2026-06-30 Analysis WACC DCF	Pharmaceuticals	$14.4B	20.9%
27	JAZZ	Jazz Pharmaceuticals plc TTM · 2026-06-30 Analysis WACC DCF	Pharmaceuticals	$14.1B	20.4%
28	LIN	Linde plc TTM · 2026-06-30 Analysis WACC DCF	Other	$224.7B	20.4%
29	BMY	BRISTOL-MYERS SQUIBB COMPANY TTM · 2026-06-30 Analysis WACC DCF	Pharmaceuticals	$117.6B	18.9%
30	PG	PROCTER & GAMBLE CO FY · 2026-06-30 Analysis WACC DCF	Other	$355.8B	18.4%
31	LNTH	LANTHEUS HOLDINGS, INC. TTM · 2026-06-30 Analysis WACC DCF	Biotechnology	$6.5B	17.7%
32	ALNY	ALNYLAM PHARMACEUTICALS, INC. TTM · 2026-06-30 Analysis WACC DCF	Pharmaceuticals	$30.4B	16.8%
33	BCPC	Balchem Corporation TTM · 2026-06-30 Analysis WACC DCF	Pharmaceuticals	$5.4B	15.1%
34	TECH	BIO-TECHNE Corp FY · 2026-06-30 Analysis WACC DCF	Pharmaceuticals	$11.4B	15.0%
35	ABT	ABBOTT LABORATORIES TTM · 2026-03-31 Analysis WACC DCF	Pharmaceuticals	$176.2B	13.9%
36	BIIB	BIOGEN INC. TTM · 2026-03-31 Analysis WACC DCF	Pharmaceuticals	$33.9B	13.8%
37	WDFC	WD-40 COMPANY TTM · 2026-05-31 Analysis WACC DCF	Other	$2.7B	13.2%
38	FTK	FLOTEK INDUSTRIES INC/CN TTM · 2026-06-30 Analysis WACC DCF	Other	$929M	13.0%
39	ECL	ECOLAB INC. TTM · 2026-06-30 Analysis WACC DCF	Other	$79.7B	12.6%
40	NAGE	NIAGEN BIOSCIENCE, INC. TTM · 2026-06-30 Analysis WACC DCF	Pharmaceuticals	$208M	12.4%
41	CHD	CHURCH & DWIGHT CO., INC. FY · 2025-12-31 Analysis WACC DCF	Other	$23.7B	11.9%
42	CLX	CLOROX CO /DE/ TTM · 2026-03-31 Analysis WACC DCF	Other	$10.2B	11.2%
43	IPAR	INTERPARFUMS, INC. TTM · 2026-06-30 Analysis WACC DCF	Other	$3.6B	11.2%
44	ANIP	ANI PHARMACEUTICALS, INC TTM · 2026-06-30 Analysis WACC DCF	Pharmaceuticals	$1.7B	11.1%
45	KVUE	Kenvue Inc. TTM · 2026-06-28 Analysis WACC DCF	Other	$34.2B	10.8%
46	PPG	PPG INDUSTRIES INC TTM · 2026-03-31 Analysis WACC DCF	Other	$23.1B	9.8%
47	CL	COLGATE-PALMOLIVE COMPANY TTM · 2026-06-30 Analysis WACC DCF	Other	$71.7B	9.7%
48	SXT	Sensient Technologies Corp TTM · 2026-06-30 Analysis WACC DCF	Other	$5.5B	9.3%
49	RPM	RPM International Inc. TTM · 2026-08-31 Analysis WACC DCF	Other	$12.4B	8.5%
50	GYRE	Gyre Therapeutics, Inc. FY · 2025-12-31 Analysis WACC DCF	Pharmaceuticals	$728M	8.5%
51	TEVA	TEVA PHARMACEUTICAL INDUSTRIES LIMITED FY · 2025-12-31 Analysis WACC DCF	Pharmaceuticals	$48.0B	8.2%
52	ABBV	AbbVie Inc. FY · 2025-12-31 Analysis WACC DCF	Pharmaceuticals	$496.8B	6.9%
53	PFE	PFIZER INC TTM · 2026-06-28 Analysis WACC DCF	Pharmaceuticals	$161.9B	6.8%
54	CORT	CORCEPT THERAPEUTICS INC TTM · 2026-06-30 Analysis WACC DCF	Pharmaceuticals	$13.1B	6.6%
55	PAHC	Phibro Animal Health Corporation FY · 2026-06-30 Analysis WACC DCF	Pharmaceuticals	$1.5B	6.6%
56	IOSP	INNOSPEC INC. FY · 2025-12-31 Analysis WACC DCF	Pharmaceuticals	$2.4B	6.6%
57	FTLF	FITLIFE BRANDS, INC. TTM · 2026-06-30 Analysis WACC DCF	Pharmaceuticals	$87M	6.2%
58	SOLS	Solstice Advanced Materials Inc. FY · 2025-12-31 Analysis WACC DCF	Pharmaceuticals	$9.6B	6.1%
59	VCEL	VERICEL CORPORATION FY · 2025-12-31 Analysis WACC DCF	Pharmaceuticals	$2.1B	6.0%
60	HXL	Hexcel Corporation TTM · 2026-06-30 Analysis WACC DCF	Other	$6.4B	5.9%
61	LXU	LSB Industries, Inc. TTM · 2026-06-30 Analysis WACC DCF	Other	$706M	5.6%
62	FUL	FULLER H B CO TTM · 2026-08-29 Analysis WACC DCF	Other	$2.7B	5.6%
63	RGEN	REPLIGEN CORP TTM · 2026-06-30 Analysis WACC DCF	Pharmaceuticals	$11.0B	5.3%
64	CBT	Cabot Corporation TTM · 2026-06-30 Analysis WACC DCF	Other	$3.8B	5.2%
65	EMN	EASTMAN CHEMICAL CO TTM · 2026-06-30 Analysis WACC DCF	Other	$7.1B	5.0%
66	MRK	Merck & Co., Inc. TTM · 2026-06-30 Analysis WACC DCF	Pharmaceuticals	$358.9B	4.8%
67	ALB	ALBEMARLE CORPORATION TTM · 2026-06-30 Analysis WACC DCF	Other	$11.6B	3.8%
68	NATR	NATURE’S SUNSHINE PRODUCTS, INC. TTM · 2026-06-30 Analysis WACC DCF	Pharmaceuticals	$224M	3.7%
69	BTMD	biote Corp. TTM · 2026-06-30 Analysis WACC DCF	Pharmaceuticals	$33M	3.2%
70	IFF	INTERNATIONAL FLAVORS & FRAGRANCES INC TTM · 2026-06-30 Analysis WACC DCF	Other	$21.7B	2.9%
71	LFVN	LIFEVANTAGE CORP FY · 2026-06-30 Analysis WACC DCF	Pharmaceuticals	$75M	2.8%
72	AVNT	AVIENT CORPORATION FY · 2025-12-31 Analysis WACC DCF	Other	$3.6B	2.5%
73	SMG	Scotts Miracle-Gro Co TTM · 2026-06-27 Analysis WACC DCF	Other	$2.9B	2.2%
74	BMRN	BIOMARIN PHARMACEUTICAL INC TTM · 2026-06-30 Analysis WACC DCF	Pharmaceuticals	$10.7B	2.1%
75	SCL	STEPAN COMPANY FY · 2025-12-31 Analysis WACC DCF	Other	$1.4B	2.0%
76	LXFR	LUXFER HOLDINGS PLC TTM · 2026-03-29 Analysis WACC DCF	Other	$466M	1.6%
77	ALTO	ALTO INGREDIENTS, INC. FY · 2025-12-31 Analysis WACC DCF	Other	$284M	1.5%
78	DD	DUPONT DE NEMOURS, INC. TTM · 2026-06-30 Analysis WACC DCF	Other	$17.5B	1.4%
79	EL	Estee Lauder Companies Inc FY · 2026-06-30 Analysis WACC DCF	Other	$36.2B	1.2%
80	APD	AIR PRODUCTS AND CHEMICALS, INC. TTM · 2026-06-30 Analysis WACC DCF	Other	$63.2B	-0.4%
81	NEOG	Neogen Corporation FY · 2026-05-31 Analysis WACC DCF	Biotechnology	$2.6B	-0.9%
82	LYB	LYONDELLBASELL INDUSTRIES N.V. TTM · 2026-06-30 Analysis WACC DCF	Other	$19.2B	-1.1%
83	SNDL	SNDL Inc. FY · 2025-12-31 Analysis WACC DCF	Pharmaceuticals	$288M	-1.7%
84	CSBR	CHAMPIONS ONCOLOGY, INC. TTM · 2026-07-31 Analysis WACC DCF	Pharmaceuticals	$69M	-1.9%
85	VHI	VALHI, INC. TTM · 2026-06-30 Analysis WACC DCF	Other	$405M	-2.4%
86	NEUP	Neuphoria Therapeutics Inc. FY · 2025-06-30 Analysis WACC DCF	Pharmaceuticals	$18M	-2.4%
87	USNA	USANA HEALTH SCIENCES, INC. TTM · 2026-07-04 Analysis WACC DCF	Pharmaceuticals	$276M	-2.4%
88	AGEN	AGENUS INC FY · 2025-12-31 Analysis WACC DCF	Pharmaceuticals	$336M	-2.7%
89	VTRS	VIATRIS INC. TTM · 2026-06-30 Analysis WACC DCF	Pharmaceuticals	$20.1B	-2.8%
90	OLN	Olin Corporation TTM · 2026-06-30 Analysis WACC DCF	Pharmaceuticals	$1.7B	-2.9%
91	MTX	MINERALS TECHNOLOGIES INC. TTM · 2026-07-05 Analysis WACC DCF	Other	$2.0B	-3.1%
92	SLSN	Solesence, Inc. TTM · 2026-06-30 Analysis WACC DCF	Other	$71M	-3.8%
93	ICCC	ImmuCell Corporation FY · 2025-12-31 Analysis WACC DCF	Biotechnology	$87M	-3.8%
94	PTCT	PTC Therapeutics, Inc. TTM · 2026-06-30 Analysis WACC DCF	Pharmaceuticals	$5.3B	-3.8%
95	EPC	EDGEWELL PERSONAL CARE COMPANY TTM · 2026-06-30 Analysis WACC DCF	Other	$1.3B	-4.5%
96	SIGA	Siga Technologies INC TTM · 2026-06-30 Analysis WACC DCF	Pharmaceuticals	$227M	-5.2%
97	MOS	MOSAIC CO TTM · 2026-06-30 Analysis WACC DCF	Other	$6.0B	-5.2%
98	ACNT	Ascent Industries Co. TTM · 2026-06-30 Analysis WACC DCF	Pharmaceuticals	$122M	-5.3%
99	KRO	KRONOS WORLDWIDE, INC. FY · 2025-12-31 Analysis WACC DCF	Other	$857M	-6.0%
100	DOW	DOW INC. FY · 2025-12-31 Analysis WACC DCF	Other	$20.3B	-6.1%